Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 188-190

  Araujo, F G ^a   Hunter, C A ^a   Remington, J S ^a  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 12; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0031020731     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.188     Document Type: Article

References (17)